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Abstract 
Objective: To assess the effectiveness of 12 weekly physical therapy sessions for urinary 
incontinence (UI) compared with a control intervention, for reducing the number of UI episodes 
measured with the 7-day bladder diary, at 3 months and 1 year postrandomization. 
Methods: A single parallel-group randomized controlled trial was conducted at one outpatient 
public health center, in postmenopausal women aged 55 years and over with osteoporosis or 
low bone density and UI. Women were randomized to physical therapy (PT) for UI or 
osteoporosis education. The primary outcome measure was number of leakage episodes on the 
7-day bladder diary, assessed at baseline, after treatment and at 1 year. The secondary outcome 
measures included the pad test and disease-specific quality of life and self-efficacy 
questionnaires assessed at the same timepoints. 
Results: Forty-eight women participated (24 per group). Two participants dropped out of each 
group and one participant was deceased before 3-month follow-up. Intention-to-treat analysis 
was undertaken. At 3 months and 1 year, there was a statistically significant difference in the 
number of leakage episodes on the 7-day bladder diary (3 mo: P = 0.04; 1 y: P = 0.01) in favor of 
the PT group. The effect size was 0.34 at 1 year. There were no harms reported. 
Conclusions: After a 12-week course of PT once per week for UI, PT group participants had a 
75% reduction in weekly median number of leakage episodes, whereas the control group's 
condition had no improvement. At 1 year, the PT group participants maintained this 
improvement, whereas the control group's incontinence worsened. 
 
 
  
Urinary incontinence (UI), defined by the International Continence Society as any involuntary 
leakage, engenders significant medical and social problems for all age groups,1 but its impact is 
most detrimental to older women. Not only is it a top health priority for this demographic of the 
population,2 it is also related to reduced physical activity, increased risk of falls, and is the 
second leading cause of admissions to long-term care.3 Although not an intrinsic outcome of 
ageing, prevalence and severity increase with age.4,5 Reported prevalence for weekly UI in 
older women ranges from 21% to 28%,6-10 and is even higher in women with osteoporosis.8 
A recent study of women attending an osteoporosis clinic over a 1-year period found that 
almost 40% of all women (163/412) reported urinary leakages one or more times per week, and 
a high prevalence of UI was accompanied by urgency.8 These findings were echoed by another 
study that also found an association between self-reported osteoporosis and disposable pad use 
(odds ratio [OR] 2.01).11 
Physical activity is a crucial component of osteoporosis treatments. It is not only important to 
preserve bone mass (grade B recommendation),12,13 it also reduces falls in adult women (grade 
A recommendation).14,15 Furthermore, UI accompanied with urgency is an independent risk 
factor for falls and low-trauma fractures in older women.16 Therefore, physical activity should 
be prescribed for all women with low bone density or osteoporosis. The co-occurring presence 
of UI, which can significantly limit a woman's ability to be physically active, makes prescription 
of physical activity more difficult.17 Therefore, UI needs to be addressed in this subpopulation. 
The mechanism by which UI prevalence is increased in women with osteoporosis is not well 
understood. One of the main hypotheses for this increased prevalence, however, is the possible 
sustained increase in intra-abdominal pressure due to changes in spinal curvature and/or spinal 
compression fracture in this subpopulation, pushing down on the pelvic floor muscle and 
eventually weakening it. In a cohort study on continent women, Sapsford et al 18 showed a 
significant reduction in pelvic floor muscle training electromyographic activity in the slump-
sitting position compared with the tall-sitting position. Therefore, spine position could influence 
the pelvic floor muscle function and render the rehabilitation more difficult. 
Previous studies investigating physical therapy and pelvic floor muscle-training (PFMT) in older 
women reported favorable results in reducing the severity of UI and changes in muscle 
morphology.19-21 However, no previous study has investigated whether a specific physical 
therapy treatment protocol, including PFMT, is effective in older women with osteoporosis and 
UI. 
Knowing whether physical therapy is effective in curing or reducing the severity of UI in this 
population is important if physicians and other healthcare professionals are to provide 
evidence-based treatment options to women with osteoporosis and UI, as well as reducing the 
burden of this condition and preventing risk of falls. 
For these reasons, a randomized controlled trial (RCT) was undertaken to assess the 
effectiveness of a proven 12-session, 3-month physical therapy UI intervention on this 
population: postmenopausal women, aged 55 years and older, with osteoporosis or low bone 
density, and stress, urge, or mixed UI. We hypothesized that the physical therapy group would 
have a statistically significant reduction in the number of leakage episodes as measured using 
the 7-day bladder diary, our primary outcome measure, as compared with a control group 
receiving only osteoporosis education. The number of leakage episodes (7-d diary) is considered 
one of the most reliable measures of success for incontinence treatment and has been widely 
used in this type of research.21,22 Participants were also followed up at 1-year 
postrandomization. 
 
METHODS 
Participants 
Community-dwelling postmenopausal women with osteoporosis or low bone density and UI 
were recruited from an osteoporosis clinic or the waitlist of a continence clinic at a public 
women's health center providing outpatient care. A brief, standardized screening questionnaire 
was completed by all women attending the clinic. Postmenopausal women with osteoporosis or 
low bone density, who also reported symptoms of UI, were invited to be screened in greater 
detail by the research assistant using a standardized protocol, to determine their eligibility for 
the study. 
Inclusion and exclusion criteria 
To participate, women were required to be postmenopausal with osteoporosis or low bone 
density, defined by a T score of -2.0 or lower for the lumbar spine or hip, or a history of a 
nontraumatic hip, vertebral, wrist, or rib fracture; 55 years and over; have symptoms of stress, 
urge, or mixed UI for at least the past 3 months and at least two UI episodes in 3 days (self-
reported); able to communicate in English (both written and verbal); and willing to give written 
consent to participate. T-score reflects the number of standard deviations (SDs) above or below 
the mean bone mineral density for young normal adults; low bone density is associated with a 
score between -1.0 and -2.5, and osteoporosis with a score of -2.5 or lower 23). 
The determination of UI type was based on answers to two standardized questions: Do you ever 
leak when you sneeze, cough, laugh, lift, bend forward, stand up from a sitting or lying position, 
walk, or run quickly? When you have a strong urge to go to the toilet, do you ever leak any urine 
before you can get to the toilet, for example, when you arrive home, or when you get up in the 
morning, or during the night? To be eligible for further screening, women had to answer yes to 
at least one or both questions. 
Exclusion criteria included previous treatments or workshops on incontinence in the past 5 
years; previous UI surgeries (except for those who had had anti-incontinence surgery at least 20 
y previously); fecal incontinence; continuous urine leakage; a current urinary tract infection; 
perineal pain or genital prolapse likely to interfere with the PFM assessment and treatment; 
previous pelvic irradiation; hormone therapy, use of vaginal estrogen, or an unstable hormone 
dose within the previous 6 months 24; use of concomitant treatments for UI during the trial 
period; severe mobility impairments requiring the use of mobility aids (that would make going 
to the toilet difficult); use of high-dose diuretics or medications to improve bladder control; 
history of radiation for pelvic organ cancers; score of less than 24 on the Mini Mental State 
Exam (MMSE)25; any other medical problem likely to interfere with treatment and evaluation 
(serious cardiovascular disease, ongoing cancer treatments, neurological conditions, psychiatric 
conditions); and individuals performing a Valsalva manoeuvre in lieu of PFM contraction. 
Design 
A single, parallel-group, RCT was conducted at the BC Women's Health Center in Vancouver, 
Canada, between September 2006 and April 2011. Computer-generated random-block 
assignment was used to randomly allocate participants to the experimental (physical therapy) or 
control (osteoporosis education and follow-up) groups. Allocation concealment was assured 
through the use of opaque, sequentially numbered, sealed envelopes. The research assistant 
revealed group assignments to the participants after completing their baseline measurement 
session. Each participant was assigned a number code corresponding to their group assignment, 
as per the computer-generated randomization. Physical therapists and participants allocated to 
the physical therapy group were aware of their allocated arm. Outcome assessors, data analysts, 
and the data collection and analysis team were blinded to group allocations. Participants were 
asked not to mention their group assignment to the evaluators. 
On the basis of the expected mean frequency of UI episodes in the two groups (6.19 episodes 
per week [mean] in control and 3.3 episodes per week [mean] in treated group) reported in a 
previous PFMT versus control RCT in aging women by Burns et al,26 and 25% attrition, a sample 
size of 48 participants was required to achieve 80% power to detect a difference between the 
two groups. 
All participants were sent a bladder diary to be completed for 7 consecutive days before each 
assessment session (pre, post, and 1 y). The bladder diary (frequency and volume chart) is a 
recommended method for assessing urinary symptoms 27 and a reliable method for 
determining the frequency of incontinent episodes.22 A bladder diary was collected from each 
participant at the start of each of the three assessment sessions. 
Additionally, two preweighed absorbent perineal pads (24-h pad test 28) with instructions were 
sent before and collected at each assessment session. The pad test, a reliable measure of urine 
loss in 24 hours,27 is recommended by the International Continence Society.29 “Mild” 
incontinence is 1.3 to 20 g, “moderate” is 21 to 74 g, and “severe” incontinence is 75 g or 
more.28 A research assistant contacted participants more than 7 days before each assessment 
to remind them of the bladder diary and 24-hour pad test, and to answer any related questions. 
 
Baseline measurement 
The baseline assessment (duration 1.5-h) included collecting the 7-day bladder diary,21,22 the 
24-hour pad test,27,29 and the following three questionnaires: the Urogenital Distress Inventory 
(UDI), the Incontinence Impact Questionnaire (IIQ), and the Geriatric Self-Perceived Efficacy 
questionnaire. The UDI documents the symptoms and the degree to which UI-associated 
symptoms are troubling (bothersome, hence distressing), with a total score ranging from 0 to 
300. Higher scores indicate more symptom bother.30 The IIQ evaluates the quality-of-life impact 
of UI around the themes of physical activity, travel, social relationships, and emotional health 
using a score ranging from 0 to 400. A high score indicates greater quality-of-life impact of UI.31 
The Geriatric Self-perceived Efficacy questionnaire assesses self-efficacy to prevent unwanted 
urine loss, with higher scores indicating higher self-efficacy.32 Vaginal palpation and 
observations during contractions were used by the assessing physical therapist to determine 
each woman's ability to perform a PFM contraction.33 All participants were instructed to record 
their home PFMT and/or other exercises (control group) in a diary provided by the research 
assistant. 
Intervention 
Physical therapy (experimental) group 
Subsequent to the baseline measurement, the physical therapy group received 12 individual 
sessions (first session was 60 min, subsequent sessions 30 min) of physical therapy for UI over 
12 weeks (once per week) at the health center from a trained physical therapist. The sessions 
included evaluation by manual digital palpation using the PERFECT Scheme 34 (session 1 only); 
education on the causes of incontinence, conservative treatment, management of constipation, 
and urge control techniques; PFM retraining using electromyography (EMG) biofeedback; motor 
control exercises; functional PFM exercises; bladder habit retraining; dietary 
recommendations/changes (as needed); and audio tapes for home use. This is the standard 
physical therapy care for women in the continence clinic at the participating center. Intervention 
protocol details and progression are described in Table 1.  
TABLE 1 Physical therapy group protocol
   
Osteoporosis education (control) group 
Subsequent to the baseline assessment, identical to that of the experimental group, control 
group participants received a group osteoporosis education session (3 h), including information 
on physical activity, diet, and medications used in the prevention and management of 
osteoporosis. The group education session was taught by a physical therapist, dietician, and a 
nurse clinician working in the osteoporosis clinic of the health center. If participants could not 
attend the group session due to scheduling conflicts, they were then given 1:1 phone or 
inperson sessions, covering the same material and their specific bone-health questions, with the 
osteoporosis program's physical therapist and/or dietician. All participants in the control group 
received an additional follow-up phone call to discuss the education session and other questions 
related to osteoporosis and bone health. One-on-one sessions with the dietician and physical 
therapist lasted 60 minutes, and follow-up phone calls ranged between 10 and 30 minutes. As a 
part of the follow-up activities, the control group participants spent 2 to 4 hours with a 
healthcare professional outside of the assessment sessions. 
Assessment after treatment 
Follow-up assessments were conducted 13 weeks after the baseline assessment (ie, the week 
after the final physical therapy session) and at 1 year. All tests were readministered at each 
assessment. 
Participants were either reimbursed for public transit costs or given free parking at the health 
center for the days they attended the assessment, evaluation, or treatment sessions. 
Data analysis 
Intention-to-treat analysis was conducted; the value at last observation was carried forward. 
The Mann-Whitney U test was used to compare the baseline number of leakage episodes, pad 
test values, age, parity, body mass index (BMI), smoking history, incontinence type (stress, urge, 
or mixed), and UDI and IIQ data between the two groups. Baseline, 3-month, and 1-year data for 
the two groups were analyzed with the Mann-Whitney U test, using SPSS statistical software 
(v.18.0). The level of significance was set at P less than 0.05 a priori. The effect size was 
calculated (r = z/square root of n). According to Cohen, an effect size of r = 0.1 is considered a 
small effect, an effect size of r = 0.3 is considered a medium effect, and an effect size of r = 0.5 is 
considered a large effect.35 
RESULTS 
Of the 114 women screened for eligibility, 47 were ineligible, 19 eligible candidates declined 
participation, and 48 were randomized (Fig. 1). Thus, 72% (48/67), of those who were eligible, 
agreed to participate.  
  
 
FIG. 1. Flow diagram on a study of postmenopausal women with osteoporosis or low bone density and 
urinary incontinence, randomly allocated to either a physical therapy group or a control group. 
  
Two physical therapy participants (8.3%) and three control (osteoporosis education) participants 
(12.5%) were lost to the 3-month follow-up. The physical therapy participants dropped out 
because of a lack of interest in the PFMT or the time commitment it entailed. The control 
participants withdrew from the study because they did not want to participate, it required too 
much commitment, or for reasons unrelated to the study (a death). Additionally, a physical 
therapy participant did not complete the 1-year follow-up due to the time requirement. Thus, a 
total of six participants (three per group) were lost to the 1-year follow-up. No participant 
withdrew or missed follow-up because of adverse effects. 
Adherence 
In the physical therapy group, 58% (14/24) of participants attended all 12 treatment sessions; 
33% (8/24) attended 10 or 11 sessions. In the control group, 38% (8/21) attended the group 
education session and 62% (13/21) received a 1:1 education session. 
At the 3-month follow-up, 33% (8/24) of participants in the physical therapy group had 
completed 100% of the home exercises, 33% (8/24) completed 70% to 99%, and one participant 
50% of the home exercises. Twenty-one percent (5/24) of the participants did not complete, 
either partially or at all, their exercise diary, although most of them reported doing the exercises 
some of the time. 
At 1 year, 78% (18/23) of the physical therapy participants continued to do the PFM exercises; 
67% (12/18) did so regularly (daily to three times a week) and 33% (6/18) occasionally (less than 
three times a week). Moreover, at the 1-year follow-up, 95% (19/20) of physical therapy 
participants responded “yes” to the question: Are you using the techniques that you were 
taught to control your urge to void? 
Baseline: group comparison 
Baseline characteristics of participants in both groups are presented in Table 2. At baseline, 
there were no significant differences between groups for age, parity, BMI, smoking, type or 
severity of incontinence, or self-perceived efficacy (Table 2). Noteworthy, the three participants 
with BMI values over 30 were all randomly allocated to the physical therapy group.  
  
TABLE 2 Baseline characteristics for the two groups, including type and severity of incontinence 
and between-group differences 
 
   
Three-month follow-up: between-group differences 
At 3 months, there was a statistically significant difference in the number of leakage episodes on 
the 7-day bladder diary (P = 0.044, effect size = 0.29), the UDI (P = 0.021), the IIQ (P = 0.018), 
and the self-perceived efficacy (P = 0.007) score in favor of the physical therapy group (Table 3). 
Although the values for the pad test were lower for the physical therapy group, the difference 
did not reach significance.  
TABLE 3 Median, 25th, and 75th percentiles, and between-group differences at 3 months 
(postintervention) 
   
One-year follow-up: between-group differences 
One year after randomization, there was a statistically significant difference in the number of 
leakage episodes on the 7-day bladder diary (P = 0.018; effect size = 0.34), the amount of 
leakage on the 24-hour pad test (P = 0.011), and the impact of UI as measured by the UDI (P = 
0.026) in favor of the physical therapy group (Table 4). Further, there was also a trend toward 
significance in IIQ and self-perceived efficacy results at 1 year, in favor of the physical therapy 
group (P = 0.082 and P = 0.081, respectively).  
  
 TABLE 4 Median, 25th and 75th percentiles, and between-group differences at 1 year (Mann-
Whitney U test) 
  
Contamination 
One control group participant had two physical therapy treatments for UI just after the 3-month 
follow-up assessment because she wanted to be in the physical therapy group, but had been 
randomized to the control group. There was some improvement in her UDI and IIQ results at 1 
year, but both the number of leakage episodes and pad weight worsened at 1 year. Another 
control group participant attended an UI education class between the baseline and 3-month 
follow-up period. According to the participant, this was by mistake, as she had been recruited 
through the clinic's waitlist and had already been scheduled for the session and forgot about the 
study protocol. The participant's results at 1 year were either similar to or worse than baseline 
for all measures. 
Adverse events 
No participant reported adverse events related to either intervention, the assessments, or 
outcome measures presented in this study. All participants were sent the study results by mail. 
All control group participants were given the opportunity to access physical therapy treatment 
through the center's continence clinic. 
 
DISCUSSION 
The PFM training has been shown to be effective in the treatment of UI compared with no 
treatment.36 Our study is the first RCT in a group of women with osteoporosis or low bone 
density, a population with a high UI prevalence. After a 12-week physical therapy program for 
UI, participants had a 75% reduction in the median number of weekly leakage episodes, 
whereas the control group's condition had no improvement: physical therapy group (8.00 [4.00-
10.50] to 2.00 [0.00-6.00]) versus control group (5.50 [2.25-16.75] to 5.50 [2.00-24.25]). At 1 
year, physical therapy participants maintained this improvement, whereas the control 
participants’ incontinence worsened, with the number of weekly leakage episodes increasing 
50% from baseline: physical therapy group 8.00 (4.00-10.50) to 2.00 (0.00-5.75) versus control 
group 5.50 (2.25-16.75) to 7.50 (1.00-23.00). Other measures of incontinence severity, including 
the pad test, self-perceived efficacy, UDI, and IIQ, showed statistically significant improvements 
in the short term for the physical therapy group. In the long term, the pad test and the UDI were 
statistically different between the two groups, favoring the treatment group. The self-perceived 
efficacy was lower at 1 year in the treatment group and higher in the control group, making the 
difference between the two groups nonsignificant. Finally, the impact of UI on quality of life was 
less in the control group, making the difference between the two groups nonsignificant. 
Our results are in agreement with the previously published trials investigating the efficacy of 
PFMT for UI treatment in women aged 60 and above. As in our study, the studies by Burns et al 
37 and Pereira et al 38 compared individual PFMT sessions, delivered by a professional, to a 
control group. Burns et al focused on women with predominant SUI. The treatment group 
received an individual (1:1) 8-week PFMT with a nurse; the control group received no 
treatment.37 In the treatment group, women had 54% fewer urinary leakages on a 1-week 
bladder diary at the end of the study; the control group had a 9% increase in urinary leakages.37 
This improvement in the treatment group and deterioration in the control group also mirrors 
our study's results. Pereira et al targeted women with SUI; the intervention included a 6-week 
individual PFMT with a physical therapist (1-h sessions, twice weekly); the control group 
received no treatment.38 There was an 89.3% reduction in urinary loss as measured by the 1-
hour pad test in the treatment group compared with a 5.94% reduction in the control group.38 
Thus, these results, which were deemed significant, also concur with those of our study. 
The strength of our study resides in the use of multiple, validated, and reliable UI outcome 
measures, investigating both the amount and number of leakage episodes in addition to 
disease-specific quality-of-life questionnaires. Moreover, a unique aspect of our intervention 
was the individualized progression in exercise training, with exercises being individualized to 
each participant's ability, rather than that of the group (ie, group approaches often require each 
participant to perform the same number of repetitions and at the same intensity, regardless of 
ability or the quality of their contraction). 
Study limitations are primarily age-related. The mean age of participants in the two groups was 
66.17 (6.66) and 67.13 (8.38) years of age, respectively; as a result, exercise adherence was 
reasonably high, with many participants performing the PFM exercises on a routine basis. 
Whether a significantly older population would adhere to or have the same results remains 
unknown, but a previous study of women aged 70 and above, who did not have osteoporosis or 
low bone density, also found positive results for exercise adherence.19 Moreover, as this study 
is the first one assessing PFMT in women with osteoporosis or low bone density, our sample size 
was limited. A larger RCT should be conducted on this subpopulation (wide range of ages) to 
generalize our study results. 
Despite our participants having a concomitant affliction of osteoporosis or low bone density, our 
results support the findings of previous physical therapy studies on PFMT in older women with 
UI. Similar to a previous study in women without osteoporosis,37 participants in the physical 
therapy group showed dramatic improvements in continence status, whereas UI symptoms 
among nontreatment control group participants worsened, underscoring the need for an 
intervention. 
 
CONCLUSIONS 
Our results suggest that incontinence in older women with osteoporosis and UI can be 
effectively treated using this conservative physical therapy protocol. Given the negative impact 
of UI on physical activity levels and the importance of physical activity to improving bone 
density, our results should be used by physicians and other healthcare providers to educate 
clients with osteoporosis and UI: they can effectively reduce or cure their incontinence with this 
PFMT. Many women believe there is nothing they can do, that UI is a normal part of aging for 
which the only options are costly drugs or invasive surgeries. Healthcare providers need to take 
an active role in educating women with osteoporosis or low bone density on how they can 
regain continence, especially given the high and expected rise in prevalence of these 
concomitant conditions given the aging baby-boomer population. Healthcare professionals and 
clients must also acknowledge that reasonable adherence to the training program is necessary 
to gain results. 
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